The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Friday, May 22, 2015 2:02:02 PM

Featured Columnists

Creating a Collective Path Forward to Optimize Value in Cancer Care Richard L. Schilsky, MD, FACP, FASCO  

Heal Thy Patient … Reflections on the Human Side of Medicine Chandrakanth Are, MBBS, FRCS, FACS  

Clinical Trial Participation: ‘Is It All Worth It?’ Lee M. Krug, MD  

More Featured Columnists

Expert Opinions

Opioid-Reduction Strategy for Postoperative Pain After Breast Cancer Surgery Patrick I. Borgen, MD  

In Search of ‘Just’ Prices: Questioning the High Cost of New Cancer Drugs Hagop M. Kantarjian, MD  

20 Years of NCCN: The Best Is Yet to Come Robert W. Carlson, MD  

More Expert Opinions

Meeting News

Practice-Changing Study: Pembrolizumab Outperforms Ipilimumab in Advanced ... Experts Debate: Can We Cure Metastatic Breast Cancer? José Baselga, MD, PhD, Inaugurated as AACR President Combination Immunotherapy Better Than Monotherapy in Advanced Melanoma More Meeting News

Journal Spotlight

ASCO Releases 2015 Report on The State of Cancer Care in America Improved Progression-Free Survival With Brentuximab Vedotin After Transpla... Impact of Informed Decision-Making on Breast Cancer Screening Radiotherapy or Not in Older Women Receiving Breast-Conserving Surgery and... More Journal Spotlights

Health-Care Policy

Bombarded With Changes in Health Care and Beyond, Gynecologic Oncologists Prepare for the Challenges Ahead After Decades of Uncertainty, the Sustainable Growth Rate Formula Is Repealed by Congress Creating a Collective Path Forward to Optimize Value in Cancer Care Health-Care Fraud and Abuse: Implications for Oncology More Health-care Policy

Drugs & Regimens

Combination Immunotherapy Better Than Monotherapy in Advanced Melanoma NCCN Posters of Interest Included Studies in Kidney, Breast, and Endometrial Cancers, Melanoma, and Cost Issues Combining Antiangiogenic and Vascular-Disrupting Agents Improves Progression-Free Survival in Persistent Ovarian Cancer Improved Progression-Free Survival With Brentuximab Vedotin After Transplantation in Hodgkin Lymphoma Patients More Drugs & Regimens

Oncology Worldwide

Noncommunicable Diseases Are the Leading Cause of Death in Low- and Middle-Income Countries How the International Innovation Grant Is Improving Cancer Care for Women in Myanmar Global Oncology Launches Global Cancer Project Map With NCI Addressing the Global Cancer Burden More Oncology Worldwide

Patient's Corner

Cancer Has Left an Indelible Mark on Me Too Young to Have Cancer I Refuse to Capitulate to Cancer Having Cancer So Early in Life Gave Me Purpose More Patient's Corner


/
More on Twitter